Central Trust Company’s St Jude Medical STJ Stock Holding History

Central Trust Company’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-15,676	Closed	-$1.26M	–	1246
2016 Q4	$1.26M	Hold	15,676	–	–	0.09%	201
2016 Q3	$1.25M	Sell	15,676 -6,000	-28%	-$484K	0.09%	196
2016 Q2	$1.69M	Buy	21,676 +21,566	+19,605%	+$1.54M	0.13%	163
2016 Q1	$6K	Hold	110	–	–	﹤0.01%	1014
2015 Q4	$7K	Hold	110	–	–	﹤0.01%	1030
2015 Q3	$7K	Hold	110	–	–	﹤0.01%	1047
2015 Q2	$8K	Sell	110 -770	-88%	-$55.6K	﹤0.01%	1059
2015 Q1	$57K	Sell	880 -84	-9%	-$5.59K	﹤0.01%	623
2014 Q4	$63K	Buy	964 +84	+10%	+$5.41K	0.01%	607
2014 Q3	$53K	Hold	880	–	–	﹤0.01%	648
2014 Q2	$61K	Hold	880	–	–	﹤0.01%	627
2014 Q1	$57K	Hold	880	–	–	﹤0.01%	646
2013 Q4	$55K	Hold	880	–	–	﹤0.01%	654
2013 Q3	$47K	Hold	880	–	–	﹤0.01%	662
2013 Q2	$40K	Buy	+880	New	+$38.1K	﹤0.01%	662

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Central Trust Company's STJ Position: Q1 2017 in Review

Central Trust Company sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 15,676 shares — an estimated $1.26M sold.

Central Trust Company first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $1.69M in Q2 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

Central Trust Company reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
Central Trust Company sold 15,676 St Jude Medical shares in Q1 2017, an estimated $1.26M.
Central Trust Company first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
Central Trust Company's St Jude Medical position peaked at $1.69M in Q2 2016.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Central Trust Company's 13F filing for Q1 2017, filed 6 Apr 2017.